DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune

Benzinga
2025.08.06 17:39

Faruqi & Faruqi, LLP is investigating claims on behalf of investors who suffered losses exceeding $75,000 in Altimmune, Inc. between August 10, 2023, and June 25, 2025. Investors are encouraged to contact partner Josh Wilson regarding their legal rights before the October 6, 2025 deadline to seek lead plaintiff status in a federal securities class action. Following disappointing trial results, Altimmune's stock price plummeted by 53.2% in one day, from $7.71 to $3.61 per share. The firm invites anyone with information about Altimmune's conduct to reach out.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.